EN455-3:1999 Requirements for biocompatibility and labelling
The essential requirements of the Directive require products to be safe when used by the end-user.
Latex Protein
Part 3 of EN455 covers the biocompatibility of medical gloves and in particular introduced a test method for the measurement of latex protein in natural rubber gloves.
The test method is based upon a modified Lowry protein assay, in which gloves are extracted with a buffer solution, containing hemisodium TES (N-tris-[hydroxymethyl]-methyl-2-aminoethanesulfonic acid, disodium salt). The gloves are shaken with the buffer for 1 hour and then the protein in the extract is precipitated from solution. The precipitate is collected by centrifugation and re-dissolved with O.1M sodium hydroxide. This solution is then treated with Bio-Rad protein assay reagent and the resulting blue coloured complex measured by colorimetry.
This method enables a comparison of the total protein content of natural rubber gloves. The limit of detection is typically less than 50 mg/g of rubber.
EN455 provides an alternative method for the determination of latex protein in the event that other components of the rubber formulation interfere with the modified Lowry method. This alternative method is based on the use of high pressure liquid chromatography (HPLC) that measures the individual amino acids which make up the latex protein. This HPLC method takes a longer time to complete and is more complicated than the modified Lowry method, so although the measurement of protein by this method is more reliable and gives the best correlation with clinical data on latex protein reactions, the modified Lowry is still defined as the standard method for measurement of latex protein.
At present there is insufficient data to indicate what level of latex protein presents a hazard of sensitisation.
Non-latex Protein Allergens
EN455-3 specifies that a list of other materials present in the glove that are capable of causing allergic reaction shall be supplied upon request by the user or other relevant body.
Endotoxins
If product is claimed to be “low endotoxin content”, EN455-3 also specifies that sterile gloves shall be subject to monitoring of endotoxin levels to establish that the endotoxin content does not exceed a maximum limit of 20 endotoxin units per pair of gloves.
Endotoxins are toxic materials which are present in the cell walls of certain types of bacteria (gram negative). These toxins remain on the gloves even though the bacteria have been killed by the sterilisation process.
Endotoxins are a type of pyrogen, which means that they can cause fever and other adverse reactions in humans. Therefore, excessive levels of endotoxin can cause post-operative problems in patients who have undergone surgery.
The test for endotoxins is based upon the Limulus Amoebocyte Lysate (LAL) test. This test uses an extract from the blood of the horseshoe crab, in which the endotoxin suppresses the natural clotting mechanism of the extract. A series of diluted extracts from gloves is placed in a small test tube with a measured amount of the extract. The test tubes are examined to establish which concentrations suppress the formation of a clot. In this way an estimate of the amount of endotoxin can be obtained.
In some cases, chemicals from the gloves may interfere with this test, in which case the standard permits an alternative test to be carried out. This test is a rabbit pyrogen test. In the rabbit pyrogen test, extracts from the glove are injected into rabbits and their body temperature measured. If a pyrogen (endotoxin) is present, a significant increase in the rabbits’ body temperature will be observed.
Top
|